Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

AGM Statement

28 Jul 2011 07:00

RNS Number : 2159L
Halma PLC
28 July 2011
Β 

ο»Ώ

Halma p.l.c.

Β 

AGM Trading Update/Interim Management Statement

Β 

28 July 2011

Β 

Β 

Halma, the leading safety, health and environmental technology group is holding its 117th AGM later today, at which Geoff Unwin, Chairman, will make the following statement which comprises the Group's Interim Management Statement relating to the period 3 April 2011 to 28 July 2011 and covers the first quarter's trading.

Β 

"Trading since the start of the financial year has been in line with the Board's expectations.

Β 

"In the first quarter, revenue was 14% ahead of last year, including a positive benefit of 8% from acquisitions and a negative impact of 2% from currency translation. Order intake was slightly ahead of revenue.

Β 

"All three sectors increased revenue and profit. Health and Analysis is benefiting strongly from the expected contribution of recent acquisitions, whilst Infrastructure Sensors is making steady progress. Industrial Safety continued to make good progress following a strong improvement in the last financial year.

Β 

"Revenue growth in UK and Europe is encouraging and exceeds the rate of growth in the USA. Good progress continues to be made in Asia.

Β 

"Since the start of the financial year, Halma has announced the completion of two acquisitions. In May, we acquired Kirk Key Interlocks, based in Ohio, USA for $14.7m (Β£9.0m) and in July we acquired AVO Photonics, based in Pennsylvania, USA for an initial consideration of $9m (Β£5.6m). Both businesses are trading in line with expectations as part of our Safety Interlocks (Industrial Safety) and Photonics (Health & Analysis) businesses respectively.

Β 

"There have been no material events or transactions impacting the Group's financial position, which remains strong. We continue to increase investment in supporting organic growth and to acquire businesses which meet our strategic and financial criteria.

Β 

"The half yearly results for the period ending 1 October 2011 are expected to be released on 22 November 2011."

Β 

Β 

Β 

For further information, please contact:

Β 

Halma p.l.c.

Andrew Williams, Group Chief Executive

Kevin Thompson, Group Finance Director

Β 

Tel: +44 (0)1494 721111

Β 

MHP Communications

Rachel Hirst/Andrew Jaques

Tel: +44 (0)20 3128 8100

Β 

Notes:

Β 

1.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

Β 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMDKODKABKDQOB
Date   Source Headline
1st Oct 20197:00 amRNSSite Visit
25th Sep 20197:00 amRNSTrading Statement
29th Jul 20199:44 amRNSDirector/PDMR Shareholding
25th Jul 20196:27 pmRNSResult of AGM
25th Jul 20197:00 amRNSNotice of Board Change
15th Jul 201911:01 amRNSHolding(s) in Company
15th Jul 201910:38 amRNSCompletion of Acquisition
4th Jul 20192:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:47 pmRNSDirector/PDMR Shareholding
2nd Jul 201910:34 amRNSHolding(s) in Company
21st Jun 201910:52 amRNSAnnual Financial Report
21st Jun 20197:00 amRNSAcquisition
11th Jun 20197:00 amRNSFinal Results
29th May 20194:00 pmRNSHolding(s) in Company
28th May 201912:59 pmRNSHolding(s) in Company
23rd May 201910:46 amRNSHolding(s) in Company
22nd May 20191:49 pmRNSHolding(s) in Company
21st May 20196:28 pmRNSHolding(s) in Company
17th May 20195:08 pmRNSHolding(s) in Company
13th May 201910:37 amRNSHolding(s) in Company
30th Apr 20199:33 amRNSHolding(s) in Company
17th Apr 201910:13 amRNSHolding(s) in Company
22nd Mar 20199:34 amRNSHolding(s) in Company
21st Mar 201912:30 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSTrading Statement
7th Feb 20192:00 pmRNSInvestor Event
18th Jan 20197:00 amRNSAcquisition
18th Dec 201811:02 amRNSDirector Declaration
20th Nov 20183:21 pmRNSDoc re. Half Year Report
20th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSAcquisition
19th Oct 20187:00 amRNSAcquisition
2nd Oct 20184:39 pmRNSDirector/PDMR Shareholding
27th Sep 20187:00 amRNSTrading Statement
2nd Aug 20183:29 pmRNSDirector/PDMR Shareholding
1st Aug 20185:23 pmRNSTotal Voting Rights
27th Jul 201810:39 amRNSDirector/PDMR Shareholding
19th Jul 20184:45 pmRNSResult of AGM
4th Jul 201810:25 amRNSDirector/PDMR Shareholding
26th Jun 20186:06 pmRNSDirector Declaration
19th Jun 20185:23 pmRNSAnnual Financial Report
12th Jun 20187:00 amRNSFinal Results
27th Mar 201810:02 amRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSTrading Statement
9th Feb 20183:49 pmRNSDirector/PDMR Shareholding
7th Feb 20182:00 pmRNSInvestor Event
16th Jan 20187:00 amRNSUS Tax Reform Update
21st Dec 20179:00 amRNSAcquisition
5th Dec 201710:10 amRNSDirector/PDMR Shareholding
21st Nov 20173:10 pmRNSDoc re. Half Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.